Naphthyl Sulfonamide Pyrrolidine Derivatives as KEAP-1 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders
CHRISTOPHER KALLUS, STEFAN GUESSREGEN, BETTINA ELSHORST, HAUKE SZILL, AIRNO KANNT, KARLRISTIAN ENGEL, PETER MONECKE, HEINER GLOMBIK, DIETER SCHMOLL, ANGELA DUDDA, SVEN RUF
Year of Publication 23.03.2016
Get full text
Year of Publication 23.03.2016
Patent